ECA
Elevated Capital Advisors’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $753K | Hold |
1,513
| – | – | 0.21% | 146 |
|
|
2025
Q1 | $753K | Sell |
1,513
-49
| -3% | -$24.4K | 0.21% | 146 |
|
|
2024
Q4 | $813K | Buy |
1,562
+11
| +0.7% | +$5.72K | 0.22% | 136 |
|
|
2024
Q3 | $959K | Buy |
1,551
+55
| +4% | +$34K | 0.25% | 113 |
|
|
2024
Q2 | $827K | Buy |
1,496
+124
| +9% | +$68.6K | 0.23% | 116 |
|
|
2024
Q1 | $797K | Buy |
1,372
+80
| +6% | +$46.5K | 0.23% | 107 |
|
|
2023
Q4 | $686K | Buy |
1,292
+153
| +13% | +$81.2K | 0.21% | 115 |
|
|
2023
Q3 | $577K | Buy |
1,139
+4
| +0.4% | +$2.03K | 0.2% | 114 |
|
|
2023
Q2 | $592K | Buy |
1,135
+80
| +8% | +$41.7K | 0.2% | 121 |
|
|
2023
Q1 | $608K | Buy |
1,055
+15
| +1% | +$8.65K | 0.22% | 114 |
|
|
2022
Q4 | $572K | Sell |
1,040
-1,642
| -61% | -$904K | 0.22% | 107 |
|
|
2022
Q3 | $1.36M | Buy |
+2,682
| New | +$1.36M | 0.54% | 62 |
|
|
2022
Q1 | $1.69M | Buy |
+2,853
| New | +$1.69M | 0.56% | 47 |
|
|
2021
Q3 | $1.68M | Buy |
+2,947
| New | +$1.68M | 0.58% | 46 |
|
|
2021
Q1 | $1.29M | Buy |
2,677
+162
| +6% | +$78.1K | 0.5% | 65 |
|
|
2020
Q4 | $1.17M | Buy |
2,515
+138
| +6% | +$64.3K | 0.51% | 57 |
|
|
2020
Q3 | $1.11M | Sell |
2,377
-455
| -16% | -$213K | 0.52% | 56 |
|
|
2020
Q2 | $1.25M | Buy |
+2,832
| New | +$1.25M | 0.59% | 52 |
|
|
2019
Q4 | $306K | Buy |
+942
| New | +$306K | 0.34% | 82 |
|
|
2019
Q1 | $681K | Buy |
+2,090
| New | +$681K | 0.45% | 82 |
|